LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 6 of 483
Next
>>
>
126 to 150 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Dovitinib	0.04	uM	LJP5	3	E24	72	hr	1334	3357	3970	0.8454	0.7671
BT-20	Enzastaurin	0.04	uM	LJP5	1	D18	72	hr	1334	3324	3970	0.8371	0.7546
BT-20	Enzastaurin	0.04	uM	LJP5	2	D18	72	hr	1334	3540	3970	0.8915	0.8365
BT-20	Enzastaurin	0.04	uM	LJP5	3	D18	72	hr	1334	4357	3970	1.0972	1.1465
BT-20	Erlotinib	0.04	uM	LJP5	1	M24	72	hr	1334	3675	3970	0.9255	0.8878
BT-20	Erlotinib	0.04	uM	LJP5	2	M24	72	hr	1334	3481	3970	0.8766	0.8142
BT-20	Erlotinib	0.04	uM	LJP5	3	M24	72	hr	1334	3883	3970	0.9779	0.9667
BT-20	Foretinib	0.04	uM	LJP5	1	H12	72	hr	1334	3769	3970	0.9492	0.9234
BT-20	Foretinib	0.04	uM	LJP5	2	H12	72	hr	1334	3928	3970	0.9892	0.9837
BT-20	Foretinib	0.04	uM	LJP5	3	H12	72	hr	1334	4154	3970	1.0461	1.0695
BT-20	R406	0.04	uM	LJP6	1	C18	72	hr	1334	2743	3970	0.6908	0.5342
BT-20	R406	0.04	uM	LJP6	2	C18	72	hr	1334	4175	3970	1.0514	1.0774
BT-20	R406	0.04	uM	LJP6	3	C18	72	hr	1334	4222	3970	1.0632	1.0952
BT-20	Pictilisib	0.04	uM	LJP6	1	D24	72	hr	1334	2477	3970	0.6238	0.4333
BT-20	Pictilisib	0.04	uM	LJP6	2	D24	72	hr	1334	3358	3970	0.8457	0.7675
BT-20	Pictilisib	0.04	uM	LJP6	3	D24	72	hr	1334	3178	3970	0.8003	0.6992
BT-20	Gefitinib	0.04	uM	LJP6	1	N12	72	hr	1334	4119	3970	1.0373	1.0562
BT-20	Gefitinib	0.04	uM	LJP6	2	N12	72	hr	1334	4089	3970	1.0297	1.0448
BT-20	Gefitinib	0.04	uM	LJP6	3	N12	72	hr	1334	4355	3970	1.0967	1.1457
BT-20	Geldanamycin	0.04	uM	LJP5	1	O06	72	hr	1334	1968	3970	0.4956	0.2402
BT-20	Geldanamycin	0.04	uM	LJP5	2	O06	72	hr	1334	1766	3970	0.4447	0.1636
BT-20	Geldanamycin	0.04	uM	LJP5	3	O06	72	hr	1334	1610	3970	0.4055	0.1044
BT-20	Geldanamycin	0.04	uM	LJP6	1	O06	72	hr	1334	1813	3970	0.4566	0.1814
BT-20	Geldanamycin	0.04	uM	LJP6	2	O06	72	hr	1334	2774	3970	0.6986	0.5460
BT-20	Geldanamycin	0.04	uM	LJP6	3	O06	72	hr	1334	1988	3970	0.5006	0.2478

|<
<<
Previous
Page 6 of 483
Next
>>
>
126 to 150 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)